Magnetic resonance in medicine

publication venue for

31P NMR spectra of extremity sarcomas: diversity of metabolic profiles and changes in response to chemotherapy. 1990
MP-RAVE: IR-Prepared T₁ -Weighted Radial Stack-of-Stars 3D GRE imaging with retrospective motion correction.. 90. 2023
Rapid anatomical imaging of the neonatal brain using T₂ -prepared 3D balanced steady-state free precession.. 89. 2022
Time-dependent diffusivity and kurtosis in phantoms and patients with head and neck cancer.. 89. 2022
Free-breathing 3D CEST MRI of human liver at 3.0 T.. 89. 2022
NIfTI-MRS: A standard data format for magnetic resonance spectroscopy.. 88. 2022
Free-breathing, non-ECG, simultaneous myocardial T₁ , T₂ , T₂ *, and fat-fraction mapping with motion-resolved cardiovascular MR multitasking.. 88. 2022
Subsecond accurate myelin water fraction reconstruction from FAST-T₂ data with 3D UNET.. 87. 2022
Estimation of the capillary level input function for dynamic contrast-enhanced MRI of the breast using a deep learning approach.. 87. 2022
Whole-brain steady-state CEST at 3 T using MR Multitasking.. 87. 2021
The macromolecular MR spectrum does not change with healthy aging.. 87. 2021
QQ-NET - using deep learning to solve quantitative susceptibility mapping and quantitative blood oxygen level dependent magnitude (QSM+qBOLD or QQ) based oxygen extraction fraction (OEF) mapping.. 87. 2021
R. 87. 2021
Dual flip-angle IR-FLASH with spin history mapping for B1+ corrected T1 mapping: Application to T1 cardiovascular magnetic resonance multitasking.. 86. 2021
Temporal clustering, tissue composition, and total variation for mapping oxygen extraction fraction using QSM and quantitative BOLD.. 86. 2021
A kinematic model-based analysis framework for 3D Cine-DENSE-validation with an axially compressed gel phantom and application in sheep before and after antero-apical myocardial infarction.. 86. 2021
Slice encoding for the reduction of outflow signal artifacts in cine balanced SSFP imaging.. 86. 2021
Multiecho complex total field inversion method (mcTFI) for improved signal modeling in quantitative susceptibility mapping.. 86. 2021
Attenuation of motion artifacts in fMRI using discrete reconstruction of irregular fMRI trajectories (DRIFT).. 86. 2021
Motion-compensated 3D turbo spin-echo for more robust MR intracranial vessel wall imaging.. 86. 2021
Bilateral gradient-echo spectroscopic imaging with correction of frequency variations for measurement of fatty acid composition in mammary adipose tissue.. 86. 2021
Free-breathing radial imaging using a pilot-tone radiofrequency transmitter for detection of respiratory motion.. 85. 2020
Frequency and phase correction of J-difference edited MR spectra using deep learning.. 85. 2020
Quantitative transport mapping (QTM) of the kidney with an approximate microvascular network.. 85. 2020
Deep neural network for water/fat separation: Supervised training, unsupervised training, and no training.. 85. 2020
QSM in canine model of acute cerebral ischemia: A pilot study.. 85. 2020
Feasibility of QSM in the human placenta.. 85. 2020
Cerebral oxygen extraction fraction: Comparison of dual-gas challenge calibrated BOLD with CBF and challenge-free gradient echo QSM+qBOLD.. 85. 2020
Training a neural network for Gibbs and noise removal in diffusion MRI.. 85. 2020
Quantification of brain oxygen extraction fraction using QSM and a hyperoxic challenge.. 84. 2020
Free-breathing fat and R₂ * quantification in the liver using a stack-of-stars multi-echo acquisition with respiratory-resolved model-based reconstruction.. 84. 2020
Quantitative susceptibility mapping of carotid plaques using nonlinear total field inversion: Initial experience in patients with significant carotid stenosis.. 84. 2020
Diffusion-weighted breast MRI of malignancies with submillimeter resolution and immunity to artifacts by spatiotemporal encoding at 3T.. 84. 2020
Dynamic T₂ mapping by multi-spin-echo spatiotemporal encoding.. 84. 2020
Dipole modeling of multispectral signal for detecting metallic biopsy markers during MRI-guided breast biopsy: a pilot study.. 83. 2019
Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO₂ ) mapping.. 83. 2019
Automated adaptive preconditioner for quantitative susceptibility mapping.. 83. 2019
Cerebral OEF quantification: A comparison study between quantitative susceptibility mapping and dual-gas calibrated BOLD imaging.. 83. 2019
Using an artificial neural network for fast mapping of the oxygen extraction fraction with combined QSM and quantitative BOLD.. 82. 2019
A regularized reconstruction pipeline for high-definition diffusion MRI in challenging regions incorporating a per-shot image correction.. 82. 2019
Comparison of gradient echo and gradient echo sampling of spin echo sequence for the quantification of the oxygen extraction fraction from a combined quantitative susceptibility mapping and quantitative BOLD (QSM+qBOLD) approach.. 82. 2019
Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencing.. 81. 2018
Rapid dynamic contrast-enhanced MRI for small animals at 7T using 3D ultra-short echo time and golden-angle radial sparse parallel MRI.. 81. 2018
Quantifying myofiber integrity using diffusion MRI and random permeable barrier modeling in skeletal muscle growth and Duchenne muscular dystrophy model in mice.. 80. 2018
Cerebral metabolic rate of oxygen (CMRO₂ ) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD).. 80. 2018
Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time.. 80. 2018
Placental perfusion imaging using velocity-selective arterial spin labeling.. 80. 2018
Simultaneous editing of GABA and glutathione at 7T using semi-LASER localization.. 80. 2017
Frequency and phase correction for multiplexed edited MRS of GABA and glutathione.. 80. 2017
MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping.. 79. 2017
Vastly accelerated linear least-squares fitting with numerical optimization for dual-input delay-compensated quantitative liver perfusion mapping.. 79. 2017
Automation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.. 79. 2017
Cardiac quantitative susceptibility mapping (QSM) for heart chamber oxygenation.. 79. 2017
Coherence enhancement in quantitative susceptibility mapping by means of anisotropic weighting in morphology enabled dipole inversion.. 79. 2017
Multiple-coil k-space interpolation enhances resolution in single-shot spatiotemporal MRI.. 79. 2017
Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance.. 79. 2017
Bone quantitative susceptibility mapping using a chemical species-specific R2* signal model with ultrashort and conventional echo data.. 79. 2017
Primal-dual and forward gradient implementation for quantitative susceptibility mapping.. 78. 2017
On the accurate analysis of vibroacoustics in head insert gradient coils.. 78. 2016
Direct SAR mapping by thermoacoustic imaging: A feasibility study.. 78. 2016
Voxelwise analysis of simultaneously acquired and spatially correlated ¹⁸ F-fluorodeoxyglucose (FDG)-PET and intravoxel incoherent motion metrics in breast cancer.. 78. 2016
Susceptibility underestimation in a high-susceptibility phantom: Dependence on imaging resolution, magnitude contrast, and other parameters.. 78. 2016
Preconditioned total field inversion (TFI) method for quantitative susceptibility mapping.. 78. 2016
Cerebral metabolic rate of oxygen (CMRO₂ ) mapping with hyperventilation challenge using quantitative susceptibility mapping (QSM).. 77. 2016
Phase unwrapping with graph cuts optimization and dual decomposition acceleration for 3D high-resolution MRI data.. 77. 2016
Robust diffusion tensor imaging by spatiotemporal encoding: Principles and in vivo demonstrations.. 77. 2016
Rapid quantitative T₂ mapping of the prostate using three-dimensional dual echo steady state MRI at 3T.. 76. 2016
Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.. 76. 2015
Surface-to-volume ratio mapping of tumor microstructure using oscillating gradient diffusion weighted imaging.. 76. 2015
Removing silicone artifacts in diffusion-weighted breast MRI by means of shift-resolved spatiotemporally encoding.. 75. 2015
Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI.. 75. 2015
Comparison of the repeatability of GABA-edited magnetic resonance spectroscopy with and without macromolecule suppression.. 75. 2015
Enhancing k-space quantitative susceptibility mapping by enforcing consistency on the cone data (CCD) with structural priors.. 75. 2015
Patch based reconstruction of undersampled data (PROUD) for high signal-to-noise ratio and high frame rate contrast enhanced liver imaging.. 74. 2014
Flexible longitudinal magnetization contrast in spectrally overlapped 3D-MSI metal artifact reduction sequences: Technical considerations and clinical impact.. 74. 2014
Comparison of fitting methods and b-value sampling strategies for intravoxel incoherent motion in breast cancer.. 74. 2014
Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using quantitative susceptibility mapping (QSM).. 74. 2014
Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites.. 74. 2014
Fast 3D T2 -weighted imaging using variable flip angle transition into driven equilibrium (3D T2 -TIDE) balanced SSFP for prostate imaging at 3T.. 74. 2014
Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.. 74. 2014
Overcoming limitations in diffusion-weighted MRI of breast by spatio-temporal encoding.. 73. 2014
Joint estimation of chemical shift and quantitative susceptibility mapping (chemical QSM).. 73. 2014
Ultrafast in vivo diffusion imaging of stroke at 21.1 T by spatiotemporal encoding.. 73. 2014
Comparison of R2' measurement methods in the normal brain at 3 Tesla.. 73. 2014
Quantification of cerebral perfusion using dynamic quantitative susceptibility mapping.. 73. 2014
Algorithm for fast monoexponential fitting based on Auto-Regression on Linear Operations (ARLO) of data.. 73. 2014
Direct coronary motion extraction from a 2D fat image navigator for prospectively gated coronary MR angiography.. 71. 2014
Referenceless reconstruction of spatiotemporally encoded imaging data: principles and applications to real-time MRI.. 72. 2014
An iterative spherical mean value method for background field removal in MRI.. 72. 2013
Pseudocontinuous arterial spin labeling with prospective motion correction (PCASL-PROMO).. 72. 2013
Golden-angle radial sparse parallel MRI: combination of compressed sensing, parallel imaging, and golden-angle radial sampling for fast and flexible dynamic volumetric MRI.. 72. 2013
Flow compensated quantitative susceptibility mapping for venous oxygenation imaging.. 72. 2013
Uncertainty in MR tracer kinetic parameters and water exchange rates estimated from T1-weighted dynamic contrast enhanced MRI.. 72. 2013
Near-contiguous spin echo imaging using matched-phase RF and its application in velocity-selective arterial spin labeling.. 71. 2013
Integrated parallel reception, excitation, and shimming (iPRES).. 70. 2013
Integration of the computational fluid dynamics technique with MRI in aortic dissections.. 69. 2012
Application of compressed sensing to multidimensional spectroscopic imaging in human prostate.. 67. 2012
Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping.. 69. 2012
Fast 3D contrast enhanced MRI of the liver using temporal resolution acceleration with constrained evolution reconstruction.. 69. 2012
Flip angle profile correction for T₁ and T₂ quantification with look-locker inversion recovery 2D steady-state free precession imaging.. 68. 2012
Bayesian algorithm using spatial priors for multiexponential T₂ relaxometry from multiecho spin echo MRI.. 68. 2012
Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping.. 68. 2012
T2 prep three-dimensional spiral imaging with efficient whole brain coverage for myelin water quantification at 1.5 tesla.. 67. 2012
A versatile flow phantom for intravoxel incoherent motion MRI.. 67. 2011
Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging.. 66. 2011
Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer.. 65. 2011
A fast Edge-preserving Bayesian reconstruction method for Parallel Imaging applications in cardiac MRI.. 65. 2011
Hippocampal blood flow in normal aging measured with arterial spin labeling at 3T.. 65. 2011
Imaging near metal with a MAVRIC-SEMAC hybrid.. 65. 2011
Respiratory and cardiac self-gated free-breathing cardiac CINE imaging with multiecho 3D hybrid radial SSFP acquisition.. 63. 2010
Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron.. 63. 2010
Effect of blood flow on double inversion recovery vessel wall MRI of the peripheral arteries: quantitation with T2 mapping and comparison with flow-insensitive T2-prepared inversion recovery imaging.. 63. 2010
Fat-free MRI based on magnetization exchange.. 63. 2010
Design and use of variable flip angle schedules in transient balanced SSFP subtractive imaging.. 63. 2010
Hyperpolarized (13)C spectroscopy and an NMR-compatible bioreactor system for the investigation of real-time cellular metabolism.. 63. 2010
Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging.. 63. 2010
Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: Application to tumors and muscle ischemia.. 62. 2009
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r.. 62. 2009
Assessment of myocardial blood flow (MBF) in humans using arterial spin labeling (ASL): feasibility and noise analysis.. 62. 2009
In vivo lactate signal enhancement using binomial spectral-selective pulses in selective MQ coherence (SS-SelMQC) spectroscopy.. 62. 2009
Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver.. 62. 2009
Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.. 62. 2009
Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue.. 61. 2009
Improved residue function and reduced flow dependence in MR perfusion using least-absolute-deviation regularization.. 61. 2009
Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI.. 61. 2009
Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field.. 60. 2008
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.. 60. 2008
Kalman filtering for real-time navigator processing.. 60. 2008
Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.. 60. 2008
Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data.. 59. 2008
Three-dimensional cine imaging using variable-density spiral trajectories and SSFP with application to coronary artery angiography.. 58. 2007
On the noise correlation matrix for multiple radio frequency coils.. 58. 2007
Modification of Gd-DTPA cystine copolymers with PEG-1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography.. 58. 2007
Bayesian parallel imaging with edge-preserving priors.. 57. 2007
Reduction of reconstruction time for time-resolved spiral 3D contrast-enhanced magnetic resonance angiography using parallel computing.. 56. 2006
Decomposed direct matrix inversion for fast non-cartesian SENSE reconstructions.. 56. 2006
Cardiac fat navigator-gated steady-state free precession 3D magnetic resonance angiography of coronary arteries.. 56. 2006
High-resolution MAS NMR spectroscopy detection of the spin magnetization exchange by cross-relaxation and chemical exchange in intact cell lines and human tissue specimens.. 55. 2006
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.. 55. 2006
Automatic algorithm for correcting motion artifacts in time-resolved two-dimensional magnetic resonance angiography using convex projections.. 55. 2006
Dependence on diffusion time of apparent diffusion tensor of ex vivo calf tongue and heart.. 54. 2005
Liver regeneration in humans is characterized by significant changes in cellular phosphorus metabolism: assessment using proton-decoupled 31P-magnetic resonance spectroscopic imaging.. 54. 2005
In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T.. 53. 2005
Characterization of intervertebral disc degeneration by high-resolution magic angle spinning (HR-MAS) spectroscopy.. 53. 2005
Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T.. 52. 2004
Imaging therapeutic response in human bone marrow using rapid whole-body MRI.. 52. 2004
In vivo tumor lactate relaxation measurements by selective multiple-quantum-coherence (Sel-MQC) transfer.. 52. 2004
In vivo study of microbubbles as an MR susceptibility contrast agent.. 52. 2004
Self-calibrated spiral SENSE.. 52. 2004
View ordering for magnetization prepared steady state free precession acquisition: application in contrast-enhanced MR angiography.. 52. 2004
Multiprocessor scheduling implementation of the simultaneous multiple volume (SMV) navigator method.. 52. 2004
High temporal and spatial resolution 4D MRA using spiral data sampling and sliding window reconstruction.. 52. 2004
In vivo 5-fluorouracil and fluoronucleotide T1 relaxation time measurements using the variable nutation angle method.. 52. 2004
Improved magnetization preparation for navigator steady-state free precession 3D coronary MR angiography.. 51. 2004
MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease.. 51. 2004
Isotropic susceptibility shift under MAS: the origin of the split water resonances in 1H MAS NMR spectra of cell suspensions.. 50. 2003
Direct monitoring of coronary artery motion with cardiac fat navigator echoes.. 50. 2003
Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, cobalt-alloy, and stainless steel stents.. 49. 2003
High-resolution in vivo CBV mapping with MRI in wild-type mice.. 49. 2003
In vivo multiple-mouse imaging at 1.5 T.. 49. 2003
Correlation between BOLD-fMRI and EEG signal changes in response to visual stimulus frequency in humans.. 49. 2003
Automatic selection of mask and arterial phase images for temporally resolved MR digital subtraction angiography.. 48. 2002
Biochemical correlates of thiazolidinedione-induced adipocyte differentiation by high-resolution magic angle spinning NMR spectroscopy.. 48. 2002
Recessed elliptical-centric view-ordering for contrast-enhanced 3D MR angiography of the carotid arteries.. 48. 2002
k-space interpretation of the Rose Model: noise limitation on the detectable resolution in MRI.. 48. 2002
Fast maximum intensity projection algorithm using shear warp factorization and reduced resampling.. 47. 2002
k-Space weighted least-squares algorithm for accurate and fast motion extraction from magnetic resonance navigator echoes.. 46. 2001
Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging.. 46. 2001
Relative changes of cerebral arterial and venous blood volumes during increased cerebral blood flow: implications for BOLD fMRI.. 45. 2001
Regional sensitivity and coupling of BOLD and CBV changes during stimulation of rat brain.. 45. 2001
Effect of hyperoxia, hypercapnia, and hypoxia on cerebral interstitial oxygen tension and cerebral blood flow.. 45. 2001
Description of parallel imaging in MRI using multiple coils.. 44. 2000
Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging.. 43. 2000
A dual-tuned resonator for proton-decoupled phosphorus-31 chemical shift imaging of the brain.. 41. 1999
Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy.. 41. 1999
In vivo chemical shift imaging of gamma-aminobutyric acid in the human brain.. 41. 1999
Quantification of myocardial perfusion by MRI after coronary occlusion.. 40. 1998
Dynamic k-space filling for bolus chase 3D MR digital subtraction angiography.. 40. 1998
Quantitative assessment of bone marrow hematopoiesis using parametric magnetic resonance imaging.. 39. 1998
Timing algorithm for bolus chase MR digital subtraction angiography.. 39. 1998
Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation.. 39. 1998
Quantitative measurements of cerebral blood flow in rats using the FAIR technique: correlation with previous iodoantipyrine autoradiographic studies.. 39. 1998
Gradient, high-resolution, magic angle spinning 1H nuclear magnetic resonance spectroscopy of intact cells.. 39. 1998
Identification of different lipid phases and calcium phosphate deposits in human carotid artery plaques by MAS NMR spectroscopy.. 39. 1998
MRI quantitative myocardial perfusion with compartmental analysis: a rest and stress study.. 38. 1997
Study of the metabolism of choline and phosphatidylcholine in tumors in vivo using phosphonium-choline.. 38. 1997
Gradient, high-resolution, magic-angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue.. 38. 1997
Dispersion in magnetization transfer contrast at a given specific absorption rate due to variations of RF pulse parameters in the magnetization transfer preparation.. 37. 1997
MR imaging and spectroscopy using hyperpolarized 129Xe gas: preliminary human results.. 37. 1997
Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography.. 37. 1997
Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies.. 36. 1996
3D MR angiography of pulmonary arteries using real-time navigator gating and magnetization preparation.. 36. 1996
Dynamic MR digital subtraction angiography using contrast enhancement, fast data acquisition, and complex subtraction.. 36. 1996
Sensitivity-enhanced echo-planar MRI at 1.5T using a 5 x 5 mesh dome resonator.. 36. 1996
Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging.. 36. 1996
Algorithms for extracting motion information from navigator echoes.. 36. 1996
Multiple breathhold 3D time-of-flight MR angiography of the renal arteries.. 35. 1996
Band-selective spin echoes for in vivo localized 1H NMR spectroscopy.. 32. 1994
Glucose metabolism in RIF-1 tumors after reduction in blood flow: an in vivo 13C and 31P NMR study.. 32. 1994
Rapid monitoring of changes in water diffusion coefficients during reversible ischemia in cat and rat brain.. 31. 1994
Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers.. 30. 1993
Sensitivity and localization enhancement in multinuclear in vivo NMR spectroscopy by outer volume presaturation.. 30. 1993
Determination of absolute phosphate metabolite concentrations in RIF-1 tumors in vivo by 31P-1H-2H NMR spectroscopy using water as an internal intensity reference.. 28. 1992
Quantitative MRI studies for assessment of multiple sclerosis.. 24. 1992
In vivo sodium chemical shift imaging.. 23. 1992
Evaluation of BA1112 rhabdomyosarcoma oxygenation with microelectrodes, optical spectrophotometry, radiosensitivity, and magnetic resonance spectroscopy.. 20. 1991
In vivo measurements of bone marrow cellularity using volume-localized proton NMR spectroscopy.. 19. 1991
In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by 19F NMR spectroscopy.. 19. 1991
Androgen sensitivity of rat prostate carcinoma studied by 31P NMR spectroscopy, 1H MR imaging, and 23Na MR imaging.. 11. 1989
MR in renal disease: importance of cortical-medullary distinction.. 5. 1987
Erratum to: Velocity-selective arterial spin labeling perfusion MRI: A review of the state of the art and recommendations for clinical implementation (Magn Reson Med. 2022; 88:1528-1547).. 89. 2022
Update on state-of-the-art for arterial spin labeling (ASL) human perfusion imaging outside of the brain. 2023
Velocity-selective arterial spin labeling perfusion MRI: A review of the state of the art and recommendations for clinical implementation. 2022
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. 2014

VIVO Weill Cornell Medical College

Magnetic resonance in medicine Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)